A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT04162769 · COMPLETED
Trial details
- NCT number
- NCT04162769
- Sponsor
- Arena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-04
- Primary completion
- 2020-09-09
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.